Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits
Source: SeekingAlpha
2025-11-30 20:47:36 ET
Since my last coverage , shares of Clover Health Investments, Corp. ( CLOV ) are down 34% as a result of disappointing Q3 earnings that saw a major spike in medical costs, leading the company to slash its adjusted EBITDA and adjusted net income guidance substantially. Despite this, I believe Clover is trading at an attractive valuation given its expected GAAP profitability in 2026....
Read the full article on Seeking Alpha
For further details see:
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits
Clover Health Investments Corp.
NASDAQ: CLOV
CLOV Trading
0.25% G/L:
$1.975 Last:
2,238,509 Volume:
$2.01 Open:
CLOV Latest News
March 10, 2026 08:30:00 am
UPDATED - Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
March 04, 2026 08:30:00 am
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
February 26, 2026 04:05:00 pm
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
CLOV Stock Data
$1,097,940,867
499,111,001
4.37%
60
N/A
Medical Service Plans
Healthcare
US
